Knoll Capital Management’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-200,000
| Closed | -$1.42M | – | 17 |
|
|
2017
Q3 | $1.42M | Hold |
200,000
| – | – | 1.21% | 8 |
|
|
2017
Q2 | $1.45M | Hold |
200,000
| – | – | 1.92% | 7 |
|
|
2017
Q1 | $1.23M | Hold |
200,000
| – | – | 1.86% | 10 |
|
|
2016
Q4 | $1.17M | Hold |
200,000
| – | – | 2.06% | 11 |
|
|
2016
Q3 | $1.03M | Hold |
200,000
| – | – | 1.81% | 12 |
|
|
2016
Q2 | $1.32M | Hold |
200,000
| – | – | 0.43% | 11 |
|
|
2016
Q1 | $934K | Hold |
200,000
| – | – | 0.38% | 12 |
|
|
2015
Q4 | $1.01M | Hold |
200,000
| – | – | 0.37% | 13 |
|
|
2015
Q3 | $704K | Hold |
200,000
| – | – | 0.3% | 13 |
|
|
2015
Q2 | $2M | Hold |
200,000
| – | – | 0.64% | 10 |
|
|
2015
Q1 | $2.55M | Hold |
200,000
| – | – | 0.74% | 7 |
|
|
2014
Q4 | $2.83M | Hold |
200,000
| – | – | 1.11% | 6 |
|
|
2014
Q3 | $2.75M | Hold |
200,000
| – | – | 1.07% | 4 |
|
|
2014
Q2 | $3.08M | Hold |
200,000
| – | – | 1.37% | 4 |
|
|
2014
Q1 | $3.41M | Hold |
200,000
| – | – | 1.76% | 5 |
|
|
2013
Q4 | $2.59M | Buy |
200,000
+100,000
| +100% | +$1.3M | 1.31% | 4 |
|
|
2013
Q3 | $1.01M | Hold |
100,000
| – | – | 0.54% | 8 |
|
|
2013
Q2 | $747K | Buy |
+100,000
| New | +$747K | 0.51% | 7 |
|